Loss of EZH2 at tumor invasive front is correlated with higher aggressiveness

Böhm J, Muenzner JK, Caliskan A, Ndreshkjana B, Erlenbach-Wunsch K, Merkel S, Croner RS, Rau TT, Geppert CI, Hartmann A, Vial-Roehe A, Schneider-Stock R (2018)

Publication Type: Conference contribution

Publication year: 2018

Journal

Cancer Research American Association for Cancer Research

Book Volume: 78

Journal Issue: 13

DOI: 10.1158/1538-7445.AM2018-3311

Authors with CRIS profile

Julian Böhm Professur für Experimentelle Tumorpathologie Benardina Ndreshkjana Professur für Experimentelle Tumorpathologie Susanne Merkel Department of Surgery Carol-Immanuel Geppert Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Arndt Hartmann Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie Regine Schneider-Stock Professur für Experimentelle Tumorpathologie

Involved external institutions

Universität Bern CH Switzerland (CH) Universidade Federal de Ciências da Saúde de Porto Alegre BR Brazil (BR)

How to cite

APA:

Böhm, J., Muenzner, J.K., Caliskan, A., Ndreshkjana, B., Erlenbach-Wunsch, K., Merkel, S.,... Schneider-Stock, R. (2018). Loss of EZH2 at tumor invasive front is correlated with higher aggressiveness.

MLA:

Böhm, Julian, et al. "Loss of EZH2 at tumor invasive front is correlated with higher aggressiveness." 2018.

BibTeX: Download